MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
260 hedge funds and large institutions have $9.15B invested in Mirati Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 94 increasing their positions, 99 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
21% less capital invested
Capital invested by funds: $11.5B → $9.15B (-$2.37B)
33% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 60
Holders
260
Holding in Top 10
11
Calls
$129M
Puts
$87.6M
Top Buyers
| 1 | +$120M | |
| 2 | +$50.2M | |
| 3 | +$47.8M | |
| 4 |
AC
Armistice Capital
New York
|
+$45.2M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$42.1M |
Top Sellers
| 1 | -$86.5M | |
| 2 | -$57.3M | |
| 3 | -$55.3M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$50.8M |
| 5 |
PA
Perceptive Advisors
New York
|
-$37.5M |